血糖仪市场报告：2030 年趋势、预测与竞争分析

血糖仪的趋势和预测

预计到 2030 年，全球血糖仪市场将达到 305 亿美元，2024 年至 2030 年复合年增长率为 8.9%。该市场的主要驱动因素是全球糖尿病盛行率不断上升、医疗基础设施成本不断上升以及糖尿病管理知识的不断增加。全球血糖仪市场的未来前景看好，机构销售、医院、诊所、零售、医院药局、零售药局和线上药局市场都有机会。

血糖机市场洞察

Lucintel 预测，由于其易于使用且价格实惠，自我血糖监测系统在预测期内仍将是最大的细分市场。

由于医院药房为医疗保健专业人员提供便利，因此将继续成为该市场的最大细分市场。

由于糖尿病盛行率高，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到2030年，全球血糖仪市场预计将达到305亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球血糖仪市场预计将以8.9%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是全球糖尿病盛行率不断上升、医疗基础设施成本不断上升以及糖尿病管理知识不断增加。

Q4.市场的主要细分市场是什么？

A4. 血糖仪市场未来性广阔，机构销售、医院、诊所、零售、医院药局、零售药局和网路药局市场都有机会。

Q5.市场上主要企业有哪些？

A5. 主要血糖仪公司如下。

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• BD
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于自我血糖监测系统易于使用且价格实惠，因此在预测期内仍将是最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于糖尿病盛行率较高，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球血糖机市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球血糖仪市场趋势（2018-2023）与预测（2024-2030）
• 全球血糖仪市场（按产品）
  • 连续血糖仪
  • 自我血糖测量系统
• 按技术分類的全球血糖仪市场
  • 侵入性的
  • 非侵入性
• 按类型分類的全球血糖仪市场
  • 穿戴式的
  • 不可穿戴
• 按分销通路分類的全球血糖仪市场
  • 设施销售
  • 医院
  • 诊所
  • 零售销售
  • 医院药房
  • 零售药房
  • 网路药房
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球血糖仪市场区域分布
• 北美血糖机市场
• 欧洲血糖仪市场
• 亚太血糖仪市场
• 其他地区血糖仪市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球血糖仪市场成长机会（按产品）
  • 全球血糖仪市场技术成长机会
  • 按类型分類的全球血糖仪市场成长机会
  • 全球血糖仪市场成长机会（按分销管道）
  • 全球血糖监测仪市场成长机会（按地区）
• 全球血糖仪市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球血糖仪市场产能
  • 全球血糖仪市场的合併、收购与合资
  • 认证和许可

第七章主要企业概况

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• BD
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Glucometer Trends and Forecast

The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

A more than 150-page report is developed to help in your business decisions.

Glucometer by Segment

The study includes a forecast for the global glucometer by product, technique, type, distribution channel, and region.

Glucometer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Continuous Glucose Monitoring Devices
• Self-Monitoring Blood Glucose Systems

Glucometer Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Invasive
• Non-Invasive

Glucometer Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Wearable
• Non-Wearable

Glucometer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Institutional Sales
• Hospitals
• Clinics
• Retail Sales
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Glucometer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Glucometer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glucometer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glucometer companies profiled in this report include-

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Glucometer Market Insights

Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.

North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Features of the Global Glucometer Market

Market Size Estimates: Glucometer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glucometer market size by various segments, such as by product, technique, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Glucometer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technique, type, distribution channel, and regions for the glucometer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glucometer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glucometer market size?

Answer: The global glucometer market is expected to reach an estimated $30.5 billion by 2030.

Q2. What is the growth forecast for glucometer market?

Answer: The global glucometer market is expected to grow with a CAGR of 8.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the glucometer market?

Answer: The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

Q4. What are the major segments for glucometer market?

Answer: The future of the glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key glucometer market companies?

Answer: Some of the key glucometer companies are as follows.

• Thermo Fisher Scientific
• Promega Corporation
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Q6. Which glucometer market segment will be the largest in future?

Answer: Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Q7. In glucometer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glucometer Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Glucometer Market by Product
  • 3.3.1: Continuous Glucose Monitoring Devices
  • 3.3.2: Self-Monitoring Blood Glucose Systems
• 3.4: Global Glucometer Market by Technique
  • 3.4.1: Invasive
  • 3.4.2: Non-Invasive
• 3.5: Global Glucometer Market by Type
  • 3.5.1: Wearable
  • 3.5.2: Non-Wearable
• 3.6: Global Glucometer Market by Distribution Channel
  • 3.6.1: Institutional Sales
  • 3.6.2: Hospitals
  • 3.6.3: Clinics
  • 3.6.4: Retail Sales
  • 3.6.5: Hospital Pharmacies
  • 3.6.6: Retail Pharmacies
  • 3.6.7: Online Pharmacies
  • 3.6.8: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Glucometer Market by Region
• 4.2: North American Glucometer Market
  • 4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
  • 4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.3: European Glucometer Market
  • 4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
  • 4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.4: APAC Glucometer Market
  • 4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
  • 4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
• 4.5: ROW Glucometer Market
  • 4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
  • 4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
  • 4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
  • 4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Glucometer Market by Product
  • 6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
  • 6.1.3: Growth Opportunities for the Global Glucometer Market by Type
  • 6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Glucometer Market by Region
• 6.2: Emerging Trends in the Global Glucometer Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Glucometer Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Promega Corporation
• 7.3: Agilent Technologies
• 7.4: Bio-Rad Laboratories
• 7.5: QIAGEN
• 7.6: Merck
• 7.7: B.D.
• 7.8: Sanofi
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: Abbott